Table 4 Prevalence of triptans users in population studies
From: Triptans in the Italian population: a drug utilization study and a literature review
Study | Country/Year | Population | Users | Period | Percentage | Females (%) |
|---|---|---|---|---|---|---|
Etemadc [8] | USA 1998–2000 | >2,000,000 | 8,488 | 1 year | <0.42 | 83.6 |
Lohmana [9] | Netherlands 2001–2002 | 168,000 | 2,343 | 1 year | 1.4 | 78 |
Perearnau [10] | France 2003–2004 | 1,793,000 | 20,686 | 1 year | 1.15 | 78.5 |
Pavone [5] | Italy 2005 | 224,065 | 1,238 | 1 year | 0.55 | 77.9 |
Dekker [11] | Netherlands 2005 | 6,700,000 | 85,172 | 1 year | 1.27 | NR |
Panconesi [6] | Italy 2006 | 5,549,731 | 32,584 | 1 year | 0.6 | 77.7 |
Iferganec [12] | Israel 2003–2004 | 500,000 | 1,498 | 1 year | 0.3 | 77.1 |
Lugardonc [13] | France 2002 | 1,550,000 | 13,860 | 6 months | 1.0 | 80.6 |
Sondergaard [14] | Denmark 2000 | 472,000 | 2,463 | 3 months | 0.52 | 82.7 |
Hoffmanb [15] | USA 1999 | 600,000 | 4,718 | 3 months | 0.78 | NR |